Doklady Biochemistry and Biophysics · 2018 · 26 citations · 13 references
PharmacyMaterials SciencePharmaceuticsDrug DeliveryNanoparticle Drug DeliveryNanotechnologyCancer NanomedicineMagnetic NanomaterialsNanomaterials For Drug DeliveryNanomedicineNanoparticle FormulationsNanoparticle SynthesisMagnetic Drug Delivery SystemsMagnetic Nanoparticle Drug CarriersMagnetic Nanoparticle Drug DeliveryMagnetic NanoparticlesMagnetiteNanoparticlesTargeted DeliveryTargeted Delivery Systems
A new method for obtaining biomodified magnetite nanoparticles for targeted delivery to cells was developed. The method is based on the use of the C-terminal fragment of the Mms6 protein, which is involved in the magnetite biomineralization during the synthesis of magnetosomes in magnetotactic bacteria Magnetospirillum magneticum AMB-1, and the barnase*barstar high-affinity protein pair. The Mms6 protein fragment is required for stabilizing magnetite, and the barnase*barstar pair mediates the interaction between nanoparticles and the component for modification. The efficiency of this method was confirmed in the synthesis of magnetite nanoparticles recognizing the HER2/neu tumor marker and in the selective labeling of HER2/neu with these nanoparticles on the surface of cancer cells.
13
Design of multivalent complexes using the barnase·barstar module
Sergey M. Deyev, Robert Waibel, August P. Schubiger et al. · Nature Biotechnology · 2003 · 191 citations
Biocomputing based on particle disassembly
Maxim P. Nikitin, Victoria O. Shipunova, Sergey M. Deyev et al. · Nature Nanotechnology · 2014 · 156 citations
Riboflavin photoactivation by upconversion nanoparticles for cancer treatment
E. V. Khaydukov, Alla N. Generalova, Oleg I. Lebedev et al. · Scientific Reports · 2016 · 122 citations · Full text
Medicine, Oncology, Pharmacology +17